• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.

作者信息

Fedor J M, Stack R S, Pryor D B, Phillips H R

出版信息

Chest. 1983 Apr;83(4):704-6. doi: 10.1378/chest.83.4.704.

DOI:10.1378/chest.83.4.704
PMID:6682029
Abstract

A 62-year-old man with obstructive hypertrophic cardiomyopathy was given sublingual nifedipine, 10 mg, during invasive hemodynamic monitoring. After 15 minutes, his left ventricular outflow gradient increased from 22 to 80 mm Hg while arterial pressure fell from 152/70 to 122/64 mm Hg. Left ventricular end-diastolic pressure increased from 15 to 22 mm Hg. These adverse hemodynamic responses may have been a result of vasodilation of the peripheral circulation induced by nifedipine. Thus, some patients with hypertrophic obstructive cardiomyopathy may develop serious hemodynamic compromise when treated with nifedipine.

摘要

相似文献

1
Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
Chest. 1983 Apr;83(4):704-6. doi: 10.1378/chest.83.4.704.
2
Use of calcium channel blockers in hypertrophic cardiomyopathy.
Am J Med. 1985 Feb 22;78(2B):43-54. doi: 10.1016/0002-9343(85)90169-x.
3
Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.硝苯地平对肥厚型心肌病患者左心室舒张异常特性的改善作用
Circulation. 1982 Mar;65(3):499-507. doi: 10.1161/01.cir.65.3.499.
4
Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?
J Am Coll Cardiol. 1983 Nov;2(5):879-86. doi: 10.1016/s0735-1097(83)80235-6.
5
Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.硝苯地平与普萘洛尔对肥厚性梗阻性心肌病患者的血流动力学影响。
Br Heart J. 1982 Jul;48(1):19-26. doi: 10.1136/hrt.48.1.19.
6
Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
Am J Cardiol. 1985 Jan 25;55(3):185B-195B. doi: 10.1016/0002-9149(85)90630-7.
7
[Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
Schweiz Med Wochenschr. 1982 Sep 18;112(38):1312-7.
8
Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy.
Clin Cardiol. 1985 Mar;8(3):176-9. doi: 10.1002/clc.4960080311.
9
Adverse effect of nifedipine on left ventricular obstruction detected by pulsed Doppler echocardiography.
Jpn Heart J. 1984 Nov;25(6):1081-4. doi: 10.1536/ihj.25.1081.
10
Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.舌下含服硝苯地平对肥厚型心肌病患者血流动力学及收缩和舒张功能的影响。
Circulation. 1985 Nov;72(5):1001-7. doi: 10.1161/01.cir.72.5.1001.

引用本文的文献

1
Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis.药物治疗对梗阻性肥厚型心肌病患者减轻流出道梗阻的疗效:一项系统评价和荟萃分析
Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):469-482. doi: 10.1093/ehjcvp/pvaf036.
2
Computational models for the prediction of adverse cardiovascular drug reactions.用于预测不良心血管药物反应的计算模型。
J Transl Med. 2019 May 22;17(1):171. doi: 10.1186/s12967-019-1918-z.
3
Drug-induced atrial fibrillation.
药物性心房颤动。
Drugs. 2012 Aug 20;72(12):1617-30. doi: 10.2165/11633140-000000000-00000.
4
Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine.钙拮抗剂中毒。维拉帕米、地尔硫䓬和硝苯地平的经验
Drug Saf. 1991 Nov-Dec;6(6):408-30. doi: 10.2165/00002018-199106060-00003.